Scientists probe MYC gene's weak spots in aggressive childhood brain cancer
NCT ID NCT07694622
First seen Jul 10, 2026 · Last updated Jul 10, 2026
Summary
This study investigates the most aggressive form of medulloblastoma, a common childhood brain tumor, focusing on tumors with high MYC gene activity. Researchers will analyze tumor tissue collected during standard surgery and grow 3D tumor models in the lab to understand how MYC drives cancer and find potential drug targets. The goal is to identify new treatment strategies tailored to this high-risk group, which currently has poor outcomes and harsh side effects from standard therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could identify new drug targets for the most aggressive form of medulloblastoma, potentially leading to more effective and less toxic treatments.
- What could go wrong
- This is an early translational study focused on lab analysis, not a treatment trial. Findings may not translate into effective therapies, and the small sample size limits generalizability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GROUP 3 MEDULLOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione Policlinico Universitario "A. Gemelli", IRCCS - UOC Neurochirurgia Infantile
Rome, Lazio, 00168, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI reads MRI scans to reveal hidden brain tumor types in children before surgery
- Parental distress may undermine treatment in children with recurrent brain tumors
- New combination therapy aims to outsmart aggressive childhood brain cancer
- Can less radiation still beat childhood brain cancer?
- New hope for kids with tough cancers: targeted drug trial launches
- New proton therapy spares spine growth in kids with brain cancer